000 01390 a2200385 4500
005 20250512214551.0
264 0 _c19820420
008 198204s 0 0 eng d
022 _a0012-6667
024 7 _a10.2165/00003495-198223010-00003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGirling, D J
245 0 0 _aAdverse effects of antituberculosis drugs.
_h[electronic resource]
260 _bDrugs
_c
300 _a56-74 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnemia, Hemolytic
_xchemically induced
650 0 4 _aAntitubercular Agents
_xadverse effects
650 0 4 _aChemical and Drug Induced Liver Injury
_xetiology
650 0 4 _aDrug Combinations
650 0 4 _aDrug Eruptions
_xetiology
650 0 4 _aDrug Hypersensitivity
_xetiology
650 0 4 _aEthambutol
_xadverse effects
650 0 4 _aHumans
650 0 4 _aIsoniazid
_xadverse effects
650 0 4 _aOptic Neuritis
_xchemically induced
650 0 4 _aPellagra
_xchemically induced
650 0 4 _aPyrazinamide
_xadverse effects
650 0 4 _aRifampin
_xadverse effects
650 0 4 _aStreptomycin
_xadverse effects
650 0 4 _aThrombocytopenia
_xchemically induced
650 0 4 _aVestibulocochlear Nerve
_xdrug effects
773 0 _tDrugs
_gvol. 23
_gno. 1-2
_gp. 56-74
856 4 0 _uhttps://doi.org/10.2165/00003495-198223010-00003
_zAvailable from publisher's website
999 _c6459817
_d6459817